“High-Deductible Health Plans Are Not the Answer”
They Cut Health Spending at First but Don’t Slow Long-Term Growth Rate, LDI Fellows Say
In Their Own Words
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.

They Cut Health Spending at First but Don’t Slow Long-Term Growth Rate, LDI Fellows Say
LDI Expert Considers Cost, Quality, and Access Implications
Better Plan Choices Would Lower Drug Costs, Not PBM Breakups, LDI’s Mark Pauly Says
LDI Expert Proposes Fixes to Keep Marketplace Plans Within Families’ Budgets
Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services by Amy Hillier